Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Seaport Global Downgrades SJW Gr to Neutral

Seaport Global analyst Angie Storozynski downgrades SJW Gr (NYSE:SJW) from Buy to Neutral.

byBenzinga Newsdesk

January 5, 2023

1 minute read

Seaport Global analyst Angie Storozynski downgrades SJW Gr (NYSE:SJW) from Buy to Neutral.

Barclays Maintains Overweight on XPO Logistics, Lowers Price Target to $110

By Benzinga Newsdesk

Today, 11:52 PM

Barclays analyst Brandon Oglenski maintains XPO Logistics (NYSE:XPO) with a Overweight and lowers the price target from $180 to $110.

XPO

General
News

Marriott Suspends All Operations In Russia – Read The Latest Update

By Shivani Kumaresan

Today, 11:52 PM

Marriott International Inc (NASDAQ:MAR) said it has decided to suspend all international operations in Russia. The decision comes as the newly…

MAR

Here’s How Much $100 Invested In Take-Two Interactive 15 Years Ago Would Be Worth Today

By Benzinga Insights

Today, 11:52 PM

Take-Two Interactive (NASDAQ:TTWO) has outperformed the market over the past 15 years by 6.39% on an annualized basis producing an average annual return of 12.95%. Currently, Take-Two Interactive has a market capitalization of $15.83 billion.

TTWO

JMP Securities Maintains Market Outperform on Arbutus Biopharma, Raises Price Target to $9

By Benzinga Newsdesk

Today, 11:52 PM

JMP Securities analyst Jason Butler maintains Arbutus Biopharma (NASDAQ:ABUS) with a Market Outperform and raises the price target from $7 to $9.

ABUS

Seaport Global Downgrades SJW Gr to Neutral

Related Posts

Barclays Maintains Overweight on XPO Logistics, Lowers Price Target to $110

Marriott Suspends All Operations In Russia – Read The Latest Update

Here’s How Much $100 Invested In Take-Two Interactive 15 Years Ago Would Be Worth Today

JMP Securities Maintains Market Outperform on Arbutus Biopharma, Raises Price Target to $9